http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020131801-A9
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c3d2897d8957967372ab255feca0c3f0 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L1-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L1-284 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B11-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 |
filingDate | 2019-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22b85c48ecab48d7c8d6507e6600e71e |
publicationDate | 2020-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-2020131801-A9 |
titleOfInvention | A sustained release composition comprising a hydroxypropyl methylcellulose acetate succinate |
abstract | A sustained release composition comprises an active ingredient mixed with a hydroxypropyl methylcellulose acetate succinate having a total degree of substitution of acetyl and succinoyl groups, DSAc + DSS, of at least 0.75, wherein the concentration of hydroxypropyl methylcellulose acetate succinate is from 0.1 to 20 % by weight of the active ingredient, and wherein the active ingredient has a solubility in water of at least 1 mg/ml. The sustained release composition is useful for preparing oral dosage form where a drug is formulated with a reduced amount of excipient(s) to permit a reduction in the overall size of the dosage form and improve the swallowability without compromising the sustained release properties thereof. |
priorityDate | 2018-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 137.